Sanofi Logo

Sanofi

Global biopharma firm researching, developing & marketing prescription medicines & vaccines.

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-13 18:54
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
French 10.0 MB
2025-10-13 18:54
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 10.1 MB
2025-10-06 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 6.4 MB
2025-10-06 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 6.3 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.6 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 444.0 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - A…
English 136.1 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT …
French 112.1 KB
2025-09-02 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.9 MB
2025-09-02 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.9 MB
2025-08-25 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

Company Country Ticker View
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896

Talk to a Data Expert

Have a question? We'll get back to you promptly.